Fractyl Health (GUTS) Change in Inventory (2023 - 2025)

Fractyl Health's (GUTS) quarterly Change in Inventory came in at -$73000.0 in Q1 2025, down 2333.33% on a QoQ basis from -$3000.0 in Q4 2023.

Fractyl Health (GUTS) Change in Inventory (2023 - 2025) Analysis & Trends

Fractyl Health (GUTS) has 2 years of Change in Inventory data on file, last reported at -$73000.0 in Q1 2025.

Quarterly Change in Inventory changed N/A year-over-year to -$73000.0 in Q1 2025, while the trailing twelve-month figure through Dec 2025 was -$73000.0 (changed N/A YoY) and the FY2025 annual result came in at -$73000.0, changed N/A from the prior year.
Change in Inventory declined to -$73000.0 in Q1 2025, from -$3000.0 in the prior quarter.
In the past five years, Change in Inventory ranged from a high of $73000.0 in Q1 2023 to a low of -$73000.0 in Q1 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Change in Inventory (Qtr)
1	Vertex Pharmaceuticals	139.20 Bn	131.35 Bn	2.84 Bn	27.70 Mn
2	Regeneron Pharmaceuticals	86.09 Bn	78.10 Bn	3.93 Bn	28.20 Mn
3	Argenx Se	65.25 Bn	60.07 Bn	1.37 Bn	-
4	Moderna	59.04 Bn	53.90 Bn	52.00 Mn	132.00 Mn
5	BeOne Medicines	42.04 Bn	36.94 Bn	1.53 Bn	47.15 Mn
6	Alnylam Pharmaceuticals	31.61 Bn	28.30 Bn	992.69 Mn	-280,000.00
7	BioNTech SE	28.04 Bn	9.65 Bn	668.28 Mn	135.26 Mn
8	Insmed	27.50 Bn	26.33 Bn	358.27 Mn	12.97 Mn
9	Royalty Pharma	27.34 Bn	26.50 Bn	-	-
10	Fractyl Health	125.68 Mn	125.68 Mn	-	-

Download Data